Celldex Therapeutics Inc (CLDX)
41.79
+0.75
(+1.83%)
USD |
NASDAQ |
Mar 27, 16:00
41.79
0.00 (0.00%)
After-Hours: 20:00
Celldex Therapeutics Max Drawdown (5Y): 99.64% for Feb. 29, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
February 29, 2024 | 99.64% |
January 31, 2024 | 99.64% |
December 31, 2023 | 99.64% |
November 30, 2023 | 99.64% |
October 31, 2023 | 99.64% |
September 30, 2023 | 99.64% |
August 31, 2023 | 99.64% |
July 31, 2023 | 99.64% |
June 30, 2023 | 99.64% |
May 31, 2023 | 99.64% |
April 30, 2023 | 99.64% |
March 31, 2023 | 99.64% |
February 28, 2023 | 99.64% |
January 31, 2023 | 99.64% |
December 31, 2022 | 99.64% |
November 30, 2022 | 99.64% |
October 31, 2022 | 99.64% |
September 30, 2022 | 99.64% |
August 31, 2022 | 99.64% |
July 31, 2022 | 99.64% |
June 30, 2022 | 99.64% |
May 31, 2022 | 99.64% |
April 30, 2022 | 99.64% |
March 31, 2022 | 99.64% |
February 28, 2022 | 99.64% |
Date | Value |
---|---|
January 31, 2022 | 99.64% |
December 31, 2021 | 99.64% |
November 30, 2021 | 99.64% |
October 31, 2021 | 99.64% |
September 30, 2021 | 99.64% |
August 31, 2021 | 99.64% |
July 31, 2021 | 99.64% |
June 30, 2021 | 99.64% |
May 31, 2021 | 99.64% |
April 30, 2021 | 99.64% |
March 31, 2021 | 99.64% |
February 28, 2021 | 99.64% |
January 31, 2021 | 99.64% |
December 31, 2020 | 99.64% |
November 30, 2020 | 99.64% |
October 31, 2020 | 99.64% |
September 30, 2020 | 99.64% |
August 31, 2020 | 99.64% |
July 31, 2020 | 99.64% |
June 30, 2020 | 99.64% |
May 31, 2020 | 99.64% |
April 30, 2020 | 99.64% |
March 31, 2020 | 99.64% |
February 29, 2020 | 99.57% |
January 31, 2020 | 99.57% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
99.39%
Minimum
Mar 2019
99.64%
Maximum
Mar 2020
99.62%
Average
99.64%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
ThermoGenesis Holdings Inc | 99.99% |
Perspective Therapeutics Inc | 91.70% |
Electromed Inc | 55.84% |
Xtant Medical Holdings Inc | 98.66% |
Asensus Surgical Inc | 99.68% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | 33.92 |
Beta (5Y) | 1.516 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 168.0% |
Historical Sharpe Ratio (5Y) | 0.3175 |
Historical Sortino (5Y) | 1.802 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 23.93% |